Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-01-14 09:02 am Purchase | 2021-01-10 | 13G | Applied DNA Sciences, Inc. APDN | Empery Asset Management LP | 32 6.420% | 32 (+6880.80%) | Filing History |
| 2021-01-14 09:00 am Purchase | 2021-01-08 | 13G | Zevra Therapeutics, Inc. ZVRA | Empery Asset Management LP | 1,230,000 9.990% | 1,230,000 (New Position) | Filing History |
| 2021-01-14 09:00 am Purchase | 2021-01-06 | 13G | Atossa Therapeutics, Inc. ATOS | Empery Asset Management LP | 4,760,500 5.320% | 4,760,500 (New Position) | Filing History |
| 2021-01-13 09:03 am Purchase | 2020-12-31 | 13G | Castor Maritime Inc. CTRM | Empery Asset Management LP | 277,333 9.910% | 130,000 (+88.24%) | Filing History |
| 2021-01-13 09:03 am Sale | 2020-12-31 | 13G | CELLECT BIOTECHNOLOGY LTD SPON APOP | Empery Asset Management LP | 185,200 0.050% | -32,114,800 (-99.43%) | Filing History |
| 2021-01-13 09:02 am Sale | 2020-12-31 | 13G | Allena Pharmaceuticals, Inc. ALNAQ | Empery Asset Management LP | 0 0.000% | -2,792,683 (Position Closed) | Filing History |
| 2021-01-13 09:02 am Unchanged | 2020-12-31 | 13G | Artelo Biosciences, Inc. ARTL | Empery Asset Management LP | 10,222 4.990% | 0 (Unchanged) | Filing History |
| 2021-01-13 09:01 am Purchase | 2020-12-31 | 13G | Baudax Bio, Inc. BXRX | Empery Asset Management LP | 714 2.600% | 714 (New Position) | Filing History |
| 2021-01-13 09:01 am Purchase | 2020-12-31 | 13G | Nuwellis, Inc. NUWE | Empery Asset Management LP | 3 4.990% | 3 (New Position) | Filing History |
| 2021-01-13 09:00 am Sale | 2020-12-31 | 13G | Aethlon Medical, Inc. AEMD | Empery Asset Management LP | 10,313 4.990% | -2,698 (-20.74%) | Filing History |
| 2021-01-07 12:47 pm Purchase | 2020-12-31 | 13G | Orbital Infrastructure Group, Inc. OIG | Empery Asset Management LP | 46,296 5.110% | 46,296 (New Position) | Filing History |
| 2020-12-08 09:40 am Purchase | 2020-12-02 | 13G | Envirotech Vehicles, Inc. ADOM | Empery Asset Management LP | 6,250,005 6.180% | 6,250,005 (New Position) | Filing History |
| 2020-12-02 11:12 am Purchase | 2020-11-25 | 13G | Hepion Pharmaceuticals, Inc. HEPA | Empery Asset Management LP | 2,000 6.910% | 2,000 (New Position) | Filing History |
| 2020-11-18 10:08 am Purchase | 2020-11-12 | 13G | InMed Pharmaceuticals Inc. INM | Empery Asset Management LP | 44 6.350% | 44 (New Position) | Filing History |
| 2020-11-12 10:38 am Purchase | 2020-11-05 | 13G | Opus Genetics, Inc. IRD | Empery Asset Management LP | 591,016 8.330% | 591,016 (New Position) | Filing History |
| 2020-11-02 12:09 pm Purchase | 2020-10-27 | 13G | Ring Energy, Inc. REI | Empery Asset Management LP | 21,428,500 9.990% | 21,428,500 (New Position) | Filing History |
| 2020-10-15 10:54 am Purchase | 2020-10-09 | 13G | Artelo Biosciences, Inc. ARTL | Empery Asset Management LP | 10,222 6.670% | 10,222 (New Position) | Filing History |
| 2020-10-15 10:53 am Purchase | 2020-10-07 | 13G | enVVeno Medical Corporation HJLI | Empery Asset Management LP | 185,864 6.200% | 185,864 (New Position) | Filing History |
| 2020-10-05 3:20 pm Purchase | 2020-09-30 | 13G | SPI ENERGY CO LTD SHS SPIEF | Empery Asset Management LP | 988,000 5.550% | 988,000 (New Position) | Filing History |
| 2020-10-05 3:17 pm Purchase | 2020-09-30 | 13G | U.S. Energy Corp. USEG | Empery Asset Management LP | 157,905 8.940% | 157,905 (New Position) | Filing History |